Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells

Chemical Research in Toxicology

Volumn 26, Issue 7, 2013, Pages 1097-1107

  Rotroff, Daniel M ^a,b   Dix, David J ^b   Houck, Keith A ^b   Kavlock, Robert J ^b   Knudsen, Thomas B ^b   Martin, Matthew T ^b   Reif, David M ^b   Richard, Ann M ^b   Sipes, Nisha S ^b   Abassi, Yama A ^c   Jin, Can ^c   Stampfl, Melinda ^c   Judson, Richard S ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c ACEA Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 TERT OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ALDOSTERONE; ANDROGEN; ANDROSTANOLONE; ANTIBIOTIC AGENT; BUTYL PARABEN; CHEMICAL AGENT; CORTICOSTEROID; CORTICOSTERONE; COSMETIC; CYPROTERONE ACETATE; DAIDZEIN; DEXAMETHASONE; DIETHYLSTILBESTROL; EQUILIN; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR; ESTRONE; FOOD ADDITIVE; GENISTEIN; GESTAGEN; HORMONE; INDUSTRIAL CHEMICAL; NONYLPHENOL; NORGESTREL; PESTICIDE; TRIAMCINOLONE; UNINDEXED DRUG; POLLUTANT;

ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL STRUCTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SENSITIVITY; ENVIRONMENTAL EXPOSURE; FOOD COMPOSITION; HUMAN; HUMAN CELL; IMPEDANCE; INTRADUCTAL CARCINOMA; MOLECULAR ELECTRONICS; PROTEIN BINDING; TRANSACTIVATION; TUMOR CELL LINE; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; HIGH THROUGHPUT SCREENING; KINETICS; METABOLISM; MOLECULAR MIMICRY; PAGET NIPPLE DISEASE; PATHOLOGY; POLLUTANT; TIME; TOXICITY TESTING;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL PROLIFERATION; ENVIRONMENTAL POLLUTANTS; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HORMONES; HUMANS; KINETICS; MOLECULAR MIMICRY; RECEPTORS, ESTROGEN; TIME FACTORS; TOXICITY TESTS;

EID: 84880294804     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx400117y     Document Type: Article

References (55)

1. Tilghman, S. L., Nierth-Simpson, E. N., Wallace, R., Burow, M. E., and McLachlan, J. A. (2010) Environmental hormones: Multiple pathways for response may lead to multiple disease outcomes Steroids 75, 520-523
2. Soto, A. M. and Sonnenschein, C. (2010) Environmental causes of cancer: endocrine disruptors as carcinogens Nat. Rev. Endocrinol. 6, 363-370
3. Davis, D. L., Telang, N. T., Osborne, M. P., and Bradlow, H. L. (1997) Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer Environ. Health Perspect. 105, 571
4. Doisneau-Sixou, S. F. 2003, Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Endocr. Relat. Cancer 10, 179-186
5. Shiozawa, T. 2004, Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence Oncogene 23, 8603-8610
6. Crowder, R. J. 2009, PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer Cancer Res. 69, 3955-3962
7. Jordan, V. C. and Morrow, M. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer Endocr. Rev. 20, 253-278
8. Oh, D. S. 2006, Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers J. Clin. Oncol. 24, 1656-1664
9. Vogel, V. G. 2006, Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of Tamoxifen and Raloxifene (STAR) P-2 trial J. Am. Med. Assoc. 295, 2727-2741
10. U.S. EPA (2011) Endocrine Disruptor Screening Program for the 21st Century: EDSP21 Work Plan. http://www.epa.gov/endo/pubs/edsp21-work-plan- summary%20-overview-final.pdf [accessed Jan 12, 2012],http://www.epa.gov/endo/ pubs/edsp21-work-plan-summary%20-overview-final.pdf.
11. U.S. EPA (2011) Response to Corrective Action Plan for OIG Report No. 11-p-0215, EPA's Endocrine Disruptor Screening Program Should Establish Management Controls to Ensure More Timely Results.
12. Rotroff, D. M. 2013, Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals Environ. Health Perspect. 121, 7
13. Schenk, B. 2010, The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants Reprod. Toxicol. 30, 200-218
14. Wang, S. 2012, Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect J. Steroid Biochem. Mol. Biol. 128, 98-106
15. Keydar, I. 1979, Establishment and characterization of a cell line of human breast carcinoma origin Eur. J. Cancer 15, 659-670
16. Judson, R. 2009, The toxicity data landscape for environmental chemicals Environ. Health Perspect. 117, 685-695
17. Kavlock, R. 2012, Update on EPA's ToxCast Program: providing high throughput decision support tools for chemical risk management Chem. Res. Toxicol. 25, 1287-1302
18. R Development Core Team (2011) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria.
19. Maechler, M. (2011) sfsmisc: Utilities from Seminar fuer Statistik ETH Zurich, R Package, version 1.0-15, ETH, Zurich, Switzerland.
20. Romanov, S. 2008, Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors Nat. Methods 5, 253-260
21. Martin, M. T. 2010, Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program Chem. Res. Toxicol. 23, 578-590
22. TM chemicals evaluated across 292 biochemical targets Toxicology 282, 1-15
23. Sipes, N. S., Martin, M. T., Kothiya, P., Reif, D. M., Judson, R. S., Richard, A. M., Houck, K. A., Dix, D. J., Kavlock, R. J., and Knudsen, T. B. (2013) Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays Chem. Res. Toxicol. 10.1021/tx400021f
24. Boonyaratanakornkit, V. 2007, The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle Mol. Endocrinol. 21, 359-375
25. Matés, J. M., Segura, J. A., Alonso, F. J., and Márquez, J. (2008) Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis Arch. Toxicol. 82, 273-299
26. Atienza, J. M., Zhu, J., Wang, X., Xu, X., and Abassi, Y. (2005) Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays J. Biomol. Screen. 10, 795-805
27. Groshong, S. D. 1997, Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27Kip1 Mol. Endocrinol. 11, 1593-1607
28. McGowan, E. M. and Clarke, C. L. (1999) Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells Mol. Endocrinol. 13, 1657-1671
29. Sartorius, C. A. 1994, New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP Cancer Res. 54, 3868-3877
30. Amato, R. 2009, Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation J. Mol. Med. 87, 1221-1239
31. Shanmugam, I. 2007, Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival Cell Death Differ. 14, 2085-2094
32. Altucci, L. 1996, 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G (1)-arrested human breast cancer cells Oncogene 12, 2315
33. Neuman, E. 1997, Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 Mol. Cell. Biol. 17, 5338-5347
34. Roy, P. G. and Thompson, A. M. (2006) Cyclin D1 and breast cancer Breast 15, 718-727
35. Blair, R. M. 2000, The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands Toxicol. Sci. 54, 138-153
36. Gaido, K. W. 1997, Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay Toxicol. Appl. Pharmacol. 143, 205-212
37. Calafat, A. M. 2005, Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population Environ. Health Perspect. 113, 391-395
38. Shelby, M. D. (2008) NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NTP CERHR MON. Sep;(22):v, vii-ix, 1-64 passim.
39. Sonnenschein, C. and Soto, A. M. (1998) An updated review of environmental estrogen and androgen mimics and antagonists J. Steroid Biochem. Mol. Biol. 65, 143-150
40. Smith, K. W. (2012) Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy Environ. Health Perspect. 120, 1538-1543
41. Okubo, T., Yokoyama, Y., Kano, K., and Kano, I. (2001) ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR Food Chem. Toxicol. 39, 1225
42. Darbre, P. D. and Harvey, P. W. (2008) Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks J. Appl. Toxicol. 28, 561-578
43. Kuiper, G. G. J. M. 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138, 863-870
44. Gustafsson, J. A. (1999) Estrogen receptor beta - a new dimension in estrogen mechanism of action J. Endocrinol. 163, 379-383
45. Pravettoni, A. 2007, Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells Mol. Cell. Endocrinol. 263, 46-54
46. Chen, A. C. and Donovan, S. M. (2004) Genistein at a concentration present in soy infant formula inhibits Caco-2BBe cell proliferation by causing G2/M cell cycle arrest J. Nutr. 134, 1303-1308
47. Peterson, G. and Barnes, S. (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells Cell Growth Differ. 7, 1345
48. Strom, A. 2006, Estrogen receptor beta inhibits 17beta-estradiol- stimulated proliferation of the breast cancer cell line T47D Proc. Natl. Acad. Sci. U.S.A. 103, 8298
49. Sotoca, A. M. 2008, Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio J. Steroid Biochem. Mol. Biol. 112, 171
50. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103, 843-852
51. Thenot, S., Charpin, M., Bonnet, S., and Cavailles, V. (1999) Estrogen receptor cofactors expression in breast and endometrial human cancer cells Mol. Cell. Endocrinol. 156, 85-93
52. Falkenstein, E., Tillmann, H. C., Christ, M., Feuring, M., and Wehling, M. (2000) Multiple actions of steroid hormones-a focus on rapid, nongenomic effects Pharmacol. Rev. 52, 513-556
53. Björnström, L. and Sjöberg, M. (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes Mol. Endocrinol. 19, 833-842
54. Watson, C. S., Jeng, Y. J., and Guptarak, J. (2011) Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways J. Steroid Biochem. Mol. Biol. 127, 44-50
55. Bunone, G., Briand, P. A., Miksicek, R. J., and Picard, D. (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation EMBO J. 15, 2174